Medizinische Hochschule Hannover

What Medizinische Hochschule Hannover does

Medizinische Hochschule Hannover (MHH) is a public medical university and maximum-care hospital located in Hannover, Lower Saxony, Germany, founded in 1965 and operated under state governance. The institution operates as an integrated academic medical center that combines three functions: patient care across all major medical disciplines (inpatient, outpatient, and emergency), academic medical education and degree programs, and clinical research with translation into practice. MHH serves a dual catchment — providing regional healthcare for the Hannover area while acting as a national referral center for complex, rare, and severe cases. Patient pricing is regulated through the German statutory and private health insurance reimbursement framework rather than through market-based pricing.

The institution's product surface is structured around three core offerings: (1) comprehensive hospital services spanning emergency treatment, inpatient care, outpatient clinics, and specialized departments; (2) medical education through degree programs and continuing professional development, supported by the Hannover Biomedical Research School (HBRS); and (3) clinical research programs in areas including COVID-19 immunology, oncology, stem cell technology, genetics, and rare diseases, conducted through centralized research facilities such as MeDIC (Medical Data Integration Center), Hannover Unified Biobank (HUB), laser microscopy, and electron microscopy. Notable technical work includes the development of industrial-scale bioreactor methods for producing pluripotent stem cells with higher yield at lower cost.

MHH's revenue model is a hybrid of state funding (Lower Saxony), statutory health insurance reimbursements (DRG-based), private health insurance billing, third-party research grants, and ancillary revenue streams such as the international patient office. The institution maintains TÜV-Nord ISO 9001 quality management certification. MHH holds German Excellence University status and engages in co-development partnerships such as the Comprehensive Cancer Center Niedersachsen (CCC-N) and the GMMG multiple myeloma study network. Marketing and stakeholder communication is conducted through the official website, social media channels, press releases, and a portfolio of branded podcasts covering research, student experience, and healthcare role models.

Name

Medizinische Hochschule Hannover

Legal name

Medizinische Hochschule Hannover

Website

https://mhh.de

Company type

Public

Founded year

1965

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Medizinische Hochschule Hannover (MHH) is a German public medical university and maximum-care hospital providing integrated patient care, medical education, and clinical research across all specialties, serving as a regional provider and national referral center for complex cases.

Ownership category

akta.pro rank

Headquarters

HQ city

Hannover, Niedersachsen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Others, Marketing or Sales

Distribution channels1 record

Marketing channels4 records

Core offering

Medizinische Hochschule Hannover (MHH) is a German state-run medical university and maximum-care hospital that delivers comprehensive inpatient, outpatient and emergency medical care across all major specialties. It also runs academic degree and postgraduate training programs (including HBRS) and conducts clinical and translational biomedical research spanning oncology, stem cells, genetics, infectious disease and rare diseases.

Product overview

Medizinische Hochschule Hannover (MHH) is a German medical university and maximum-care hospital offering integrated healthcare services, medical education, and clinical research. The institution operates as a unified academic medical center combining patient care, research, and teaching. Its core offerings span comprehensive medical treatment across all specialties, medical degree programs and continuing education, and translation-oriented clinical research. The university maintains specialized research centers including MeDIC (Medical Data Integration Center), Hannover Unified Biobank (HUB), laser microscopy, and electron microscopy facilities. Supplementary offerings include employee wellness programs and various educational podcasts.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical University Hospital Services

Segments1 record

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered core.

• Comprehensive Cancer Center Niedersachsen (CCC-N)coreStrategic or Co-development PartnerCCC-N is a collaborative cancer research network in Lower Saxony that works jointly with MHH on cancer research initiatives. The MHH serves as a key institutional partner in the network, co-organizing events such as the Johann-Georg-Zimmermann-Preis award ceremony.
• GMMG-Studiengruppe (German Speaking Myeloma Multicenter Group)coreStrategic or Co-development PartnerInternational clinical research network focused on multiple myeloma. Led by Prof. Dr. Hartmut Goldschmidt at Universitätsklinikum Heidelberg and NCT Heidelberg, with MHH hosting the award ceremony and maintaining collaborative ties through research networks.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Direct peers

• Universitätsklinikum Freiburg: Public German university hospital offering comprehensive specialty care, biomedical research, and medical education. Comparable to MHH as a mid-to-large Excellence-affiliated maximum-care academic center.
• LMU Klinikum (Ludwig-Maximilians-Universität München): Public university hospital of LMU Munich, one of Germany's largest maximum-care centers. Directly comparable to MHH in scale, scope of specialties, research output, and Excellence University affiliation.
• Universitätsklinikum Heidelberg: Public German university hospital and partner of NCT Heidelberg, hosting the GMMG myeloma study group leadership. Highly comparable to MHH as a maximum-care academic medical center with strong oncology and translational research focus.
• Universitätsklinikum Köln: Public university hospital of Cologne, providing maximum-care services and academic medical training. Direct peer to MHH in structure, funding model, and clinical-research scope.
• Universitätsklinikum Würzburg: Public university hospital of Würzburg with strong research focus and maximum-care clinical services. Comparable to MHH as a German Excellence-affiliated public academic medical center.
• Universitätsklinikum Erlangen: Public university hospital affiliated with Friedrich-Alexander-Universität Erlangen-Nürnberg. Comparable to MHH as a Bavarian/Franconian maximum-care academic medical center of similar scale and funding model.
• Universitätsklinikum Hamburg-Eppendorf (UKE): Hamburg's public university hospital and academic medical center. Comparable to MHH as a full-service maximum-care provider with significant research portfolio; UKE-based researcher Dr. Janna Heide received the MHH-co-organized Zimmermann Research Prize in 2026.
• Universitätsklinikum Münster (UKM): Public university hospital in North Rhine-Westphalia providing maximum-care services and academic medical training. Direct peer to MHH in operating model, scale, and research positioning.
• Universitätsklinikum Tübingen: Public Baden-Württemberg university hospital with strong specialty programs in oncology, rare diseases, and translational research. Comparable to MHH in being a state-funded maximum-care academic medical center competing in similar research domains.
• Charité – Universitätsmedizin Berlin: Germany's largest university hospital, jointly operated by Humboldt and Freie Universität Berlin. Directly comparable to MHH as a public maximum-care academic medical center combining clinical care, biomedical research, and medical education, and competing for the same national research grants and clinical referrals.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/MHH_nova
• Facebookde-de.facebook.com/MHHnova
• LinkedInlinkedin.com/school/medizinische-hochschule-hannover
• Instagraminstagram.com/medizinischehochschule

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medizinische Hochschule Hannover